Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1981 1
1982 1
1983 2
1985 5
1986 2
1987 1
1988 3
1989 3
1990 1
1992 2
1993 2
1994 9
1995 6
1996 2
1997 1
1998 6
1999 2
2000 3
2001 6
2002 2
2003 2
2005 3
2006 6
2007 3
2008 6
2009 6
2010 8
2011 13
2012 13
2013 15
2014 7
2015 9
2016 12
2017 16
2018 12
2019 13
2020 7
2021 9
2022 11
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Results by year

Filters applied: . Clear all
Page 1
The roles of tertiary lymphoid structures in chronic diseases.
Sato Y, Silina K, van den Broek M, Hirahara K, Yanagita M. Sato Y, et al. Among authors: hirahara k. Nat Rev Nephrol. 2023 Aug;19(8):525-537. doi: 10.1038/s41581-023-00706-z. Epub 2023 Apr 12. Nat Rev Nephrol. 2023. PMID: 37046081 Free PMC article. Review.
Single-cell immunoprofiling after immunotherapy for allergic rhinitis reveals functional suppression of pathogenic TH2 cells and clonal conversion.
Iinuma T, Kiuchi M, Hirahara K, Kurita J, Kokubo K, Yagyu H, Yoneda R, Arai T, Sonobe Y, Fukuyo M, Kaneda A, Yonekura S, Nakayama T, Okamoto Y, Hanazawa T. Iinuma T, et al. Among authors: hirahara k. J Allergy Clin Immunol. 2022 Oct;150(4):850-860.e5. doi: 10.1016/j.jaci.2022.06.024. Epub 2022 Jul 19. J Allergy Clin Immunol. 2022. PMID: 35863510 Free article.
CD69 Imposes Tumor-Specific CD8+ T-cell Fate in Tumor-Draining Lymph Nodes.
Koyama-Nasu R, Kimura MY, Kiuchi M, Aoki A, Wang Y, Mita Y, Hasegawa I, Endo Y, Onodera A, Hirahara K, Motohashi S, Nakayama T. Koyama-Nasu R, et al. Among authors: hirahara k. Cancer Immunol Res. 2023 Aug 3;11(8):1085-1099. doi: 10.1158/2326-6066.CIR-22-0406. Cancer Immunol Res. 2023. PMID: 37216576
Pathogenic helper T cells.
Hirahara K, Aoki A, Nakayama T. Hirahara K, et al. Allergol Int. 2021 Apr;70(2):169-173. doi: 10.1016/j.alit.2021.02.001. Epub 2021 Feb 23. Allergol Int. 2021. PMID: 33637414 Free article. Review.
The USP7-STAT3-granzyme-Par-1 axis regulates allergic inflammation by promoting differentiation of IL-5-producing Th2 cells.
Kumagai J, Kiuchi M, Kokubo K, Yagyu H, Nemoto M, Tsuji K, Nagahata K, Sasaki A, Hishiya T, Onoue M, Shinmi R, Sonobe Y, Iinuma T, Yonekura S, Shinga J, Hanazawa T, Koseki H, Nakayama T, Yokote K, Hirahara K. Kumagai J, et al. Among authors: hirahara k. Proc Natl Acad Sci U S A. 2023 Dec 5;120(49):e2302903120. doi: 10.1073/pnas.2302903120. Epub 2023 Nov 28. Proc Natl Acad Sci U S A. 2023. PMID: 38015852
Pathogenicity of acquired immunity in human diseases.
Hirahara K. Hirahara K. Semin Immunopathol. 2019 May;41(3):279-281. doi: 10.1007/s00281-019-00739-2. Epub 2019 May 7. Semin Immunopathol. 2019. PMID: 31065764 No abstract available.
Th2 Cells in Health and Disease.
Nakayama T, Hirahara K, Onodera A, Endo Y, Hosokawa H, Shinoda K, Tumes DJ, Okamoto Y. Nakayama T, et al. Among authors: hirahara k. Annu Rev Immunol. 2017 Apr 26;35:53-84. doi: 10.1146/annurev-immunol-051116-052350. Epub 2016 Nov 28. Annu Rev Immunol. 2017. PMID: 27912316 Review.
Maintenance of pathogenic Th2 cells in allergic disorders.
Shinoda K, Hirahara K, Nakayama T. Shinoda K, et al. Among authors: hirahara k. Allergol Int. 2017 Jul;66(3):369-376. doi: 10.1016/j.alit.2017.03.005. Epub 2017 Apr 5. Allergol Int. 2017. PMID: 28391979 Free article. Review.
224 results